Lipocine Inc (NASDAQ: LPCN) stock closed at $4.79 on 3/13/24 after a major increase of 21.0%. Moreover, trading volume in this advance was exceptionally high at 357% of normal. The stock has been weak relative to the market over the last nine months but has risen 31.6% during the last week.
Current PriceTarget Research Rating
LPCN is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Lipocine has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Lipocine has a slightly positive Appreciation Score of 61 but a poor Power Rating of 24, leading to the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment